Cargando…
Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
Background: Chile has achieved the highest coverage for vaccines against the SARS-CoV-2 virus worldwide. Objective: To assess the progression of immunity (natural and acquired by vaccine) in a cohort from two Chilean cities. Methods: Individuals (n = 386) who participated in three phases of populati...
Autores principales: | Núñez-Franz, Loreto, Ramírez-Santana, Muriel, Rubilar, Paola, Vial, Cecilia, Apablaza, Mauricio, González, Claudia, Said, Macarena, Olivares, Kathya, Cortés, Lina Jimena, Hormazábal, Juan, Canales, Luis, Vial, Pablo, Icaza, Gloria, Quezada-Gaete, Rubén, Aguilera, Ximena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861850/ https://www.ncbi.nlm.nih.gov/pubmed/36680241 http://dx.doi.org/10.3390/v15010201 |
Ejemplares similares
-
Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
por: Aguilera, Ximena, et al.
Publicado: (2022) -
Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
por: Hormazábal, Juan, et al.
Publicado: (2023) -
SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
por: Aguilera, Ximena, et al.
Publicado: (2022) -
Seroprevalence, spatial distribution, and social determinants of SARS-CoV-2 in three urban centers of Chile
por: Vial, Pablo, et al.
Publicado: (2022) -
First wave of SARS-CoV-2 in Santiago Chile: Seroprevalence, asymptomatic infection and infection fatality rate
por: Vial, Pablo A., et al.
Publicado: (2022)